<p>Artificial intelligence drug developer Absci announced a collaboration with Oracle and AMD to accelerate the process of generative AI-driven drug discovery. The company's drug discovery platform will utilize Oracle's AI infrastructure and AMD's latest hardware</p>

ORCL

AMDL

<p>The artificial intelligence drug developer Absci announced a collaboration with Oracle and AMD to accelerate the generative AI-driven drug discovery process. The company's drug discovery platform will utilize Oracle's AI infrastructure and AMD's latest hardware</p>

AI 药物开发商 Absci 与甲骨文和 AMD 达成合作